Table of Content

1 Market Guides 
1.1 Respiratory Infections Dx Market, Situation Analysis & Impact of COVID-19 
1.2 Guide for Executives, Marketing, Sales and Business Development Staff 
1.3 Guide for Management Consultants and Investment Advisors 

2 Introduction and Market Definition 
2.1 What are Respiratory Infections?
2.2 The Role of Diagnosis & Treatment 
2.3 Market Definition 
2.3.1 Revenue Market Size 
2.4 Methodology 
2.4.1 Authors
2.4.2 Sources 
2.5 A Spending Perspective on Clinical Laboratory Testing 
1.5.1 An Historical Look at Clinical Testing 

3 Market Overview 
3.1 Players in a Dynamic Market 
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer 
3.1.3 Instrumentation Supplier 
3.1.4 Distributor and Reagent Supplier 
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab 
3.1.7 Hospital lab
3.1.8 Physician Office Labs 
3.1.9 Audit Body 
3.1.10 Certification Body 
3.2 Respiratory Infections
3.2.1 Upper vs. Lower - Marketing Implications 
3.2.2 Understanding the Role of Pneumonia 
3.2.3 Bacterial Infections 
3.2.3.1 Streptococcal Infections 
3.2.3.2 Acute Otitis Media 
3.2.3.3 Bacterial Rhinosinusitis 
3.2.3.4 Diphtheria
3.2.3.5 Pneumococcal Pneumonia 
3.2.3.6 Haemophilus Pneumonia 
3.2.3.7 Mycoplasma Pneumonia (Walking Pneumonia) 
3.2.3.8 Chlamydial Pneumonias and Psittacosis 
3.2.3.9 Health Care-Associated Pneumonia 
3.2.3.10 Pseudomonas Pneumonia 
3.2.3.11 Legionnaires Disease 
3.2.4 Tuberculosis - A Special Case 
3.2.5 Viral Infections
3.2.5.1 The Common Cold
3.2.5.2 Influenza 
3.2.5.3 Viral Pneumonia 
3.2.5.4 SARS and MERS 
3.2.5.5 Measles (Rubeola)
3.2.5.6 Rubella (German Measles)
3.2.5.7 Chickenpox and Shingles 
3.2.6 Fungal and Other Pathogens
3.2.6.1 Histoplasmosis 
3.2.6.2 Coccidioidomycosis
3.2.6.3 Blastomycosis 
3.2.6.4 Mucormycosis 
3.2.6.5 Aspergillosis 
3.2.6.6 Pneumocystis Pneumonia 
3.2.6.7 Cryptococcosis
3.3 Diagnostics - A Changing Role 
3.3.1 Historical Practice 
3.3.2 Current Diagnostics 
3.3.3 The Multiplex Vector
3.3.4 Future Diagnostics - The Question of When and Where 
3.3.5 Respiratory Infection Diagnostics - The Destination
3.3.6 Diagnostics as Defensive Weapons
3.4 COVID-19 
3.4.1 Signs and symptoms 
3.4.2 Transmission 
3.4.3 Diagnosis
3.4.4 Prevention 
3.4.5 Management
3.4.6 Prognosis 
3.5 Pandemic Diagnostics
3.5.1 Risk Management - Spark and Spread
3.5.2 Dx Technology - Nucleic Acid Based
3.5.3 Dx Technology - Immunoassay & Serology
3.5.4 Time to Market and Preparedness Issues 
3.5.5 Unrecognized Role of Multiplex in Pandemic Mangement 

4 Market Trends
4.1 Factors Driving Growth 
4.1.1 Syndromic Multiplexing 
4.1.2 T.A.T
4.1.3 Antimicrobial Resistance Movement
4.1.4 Pandemic Mitigation
4.1.5 An Aging at Risk Population 
4.2 Factors Limiting Growth 
4.2.1 The Cost Curve
4.2.2 Regulation and coverage 
4.2.3 Laissez Faire 
4.3 Instrumentation and Automation 
4.3.1 The Shrinking Multiplexing Machine 
4.3.2 Bioinformatics Networking and Anonymous Reporting 
4.4 Diagnostic Technology Development  
4.4.1 The Key Role of Time to Result 
4.4.2 Single Cell Genomics Changes the Picture 
4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 
4.4.4 Pathogen Identification - A Projected Timetable of the Future 

5 Respiratory Infection Diagnostics Recent Developments 
5.1 Recent Developments - Importance and How to Use This Section 
5.1.1 Importance of These Developments 
5.1.2 How to Use This Section 
5.2 Luminex to Develop Covid/Flu/RSV Test  
5.3 Becton Dickinson Charts Transition of COVID Diagnostics
5.4 MiRxes Receives Approval for Multiplex Covid/Flu Test 
5.5 New Silicon-Based Test for Infectious Disease Screening 
5.6 GenMark to Meet Demand for Respiratory Panel 
5.7 Tempus Announces COVID-19 Testing, Data Initiative
5.8 Abacus Diagnostica Readying Multiplex Respiratory Test 
5.9 Qiagen Acquires NeuMoDx Molecular
5.10 Companies Shift to Multiplex Tests for SARS-CoV-2, Influenza 
5.11 Novacyt Gets CE Mark for Coronavirus, Flu, RSV Combo Panel 
5.12 Cepheid Debuts 10-Color Technology With New Tuberculosis Test 
5.13 BioMérieux's Pneumonia Panel Could Improve Care 
5.14 Mammoth Biosciences Announces CRISPR-Based C19 Diagnostic
5.15 Genetic Signatures Gets CE Mark for C19 Molecular Test 
5.16 Qiagen Respiratory Panel with C19 Receives CE Mark
5.17 Lumos Diagnostics Closes $15M Series A Funding 
5.18 Fusion Genomics to Assess NGS Respiratory Tract Assay 
5.19 C19 Test Development by Co-Diagnostics
5.20 Rapid Diagnostics Completes Purchase of Enigma Diagnostics 
5.21 Flu-Like Epidemic Could Kill 80 Mn Globally 
5.22 Startup developing AI for TB detection
5.23 Nipah Virus a Global Threat 
5.24 Novacyt S.A.: New Respiratory Panel Ready for US Market 
5.25 New DRC Ebola cases confirmed as FDA OKs Test 
5.26 ResApp Awarded CE Mark for Phone-based Respiratory Test 
5.27 Curetis Submits Lower Respiratory Tract Infection Test for FDA Clearance 
5.28 New test diagnoses pneumonia and other lower respiratory infections
5.29 Ontera Awarded Contract for Zika Genotyping Test
5.30 Two New Members Join Global Diagnostics Network
5.31 BARDA Funding Health Security Solutions

6 Profiles of Key Players 
6.1 Abacus Diagnostica 
6.2 Abbott Diagnostics 
6.3 Accelerate Diagnostics 
6.4 Ador Diagnostics 
6.5 Akonni Biosystems  
6.6 Alveo Technologies
6.7 Applied BioCode
6.8 Aus Diagnostics 
6.9 Beckman Coulter Diagnostics 
6.10 Becton, Dickinson and Company 
6.11 Binx Health 
6.12 Biocartis 
6.13 bioMérieux Diagnostics
6.14 Bio-Rad Laboratories, Inc
6.15 Bosch Healthcare Solutions GmbH
6.16 Cepheid (now Danaher)
6.17 Co Diagnostics 
6.18 Credo Diagnostics Biomedical 
6.19 Cue Health
6.20 Curetis N.V. / Curetis GmbH 
6.21 Diagenode Diagnostics 
6.22 Diascopic 
6.23 Diasorin S.p.A
6.24 Enzo Life Sciences, Inc
6.25 Eurofins Scientific 
6.26 Fluxergy 
6.27 Fulgent Genetics 
6.28 Fusion Genomics
6.29 Genetic Signatures
6.30 GenMark Dx 
6.31 Hibergene Diagnostics 
6.32 Hologic 
6.33 Immunexpress 
6.34 Inflammatix 
6.35 Invetech 
6.36 Janssen Diagnostics  
6.37 Karius 
6.38 Lexagene 
6.39 LightDeck Diagnostics 
6.40 Luminex Corp
6.41 Lumos Diagnostics 
6.42 Mammoth Biosciences 
6.43 Maxim Biomedical 
6.44 Meridian Bioscience 
6.45 Mesa Biotech
6.46 Millipore Sigma 
6.47 Mindray 
6.48 Mobidiag
6.49 Mologic 
6.50 Nanomix 
6.51 Operon 
6.52 Oxford Nanopore Technologies 
6.53 Panagene 
6.54 Perkin Elmer
6.55 Primerdesign 
6.56 Prominex
6.57 Qiagen Gmbh 
6.58 Quantumdx
6.59 Quidel 
6.60 Roche Molecular Diagnostics 
6.61 Saw Diagnostics 
6.62 Seegene
6.63 Siemens Healthineers 
6.64 Sona Nanotech 
6.65 SpeeDx 
6.66 T2 Biosystems
6.67 Thermo Fisher Scientific Inc
6.68 Veramarx 
6.69 Veredus Laboratories
6.70 Visby Medical 
6.71 XCR Diagnostics 

7 The Global Market for Respiratory Infection Diagnostics 
7.1 Global Market by Country 
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country 
7.2 Global Market by Technology - Overview 
7.2.1 Table - Global Market by Technology 
7.2.2 Chart - Global Market by Technology - Base/End Year Comparison
7.2.3 Chart - Global Market by Technology - Base Year 
7.2.4 Chart - Global Market by Technology - End Year
7.2.5 Chart - Global Market by Technology - Share by Year 
7.2.6 Chart - Global Market by Technology - Segment Growth
7.3 Global Market by Plex - Overview
7.3.1 Table - Global Market by Plex
7.3.2 Chart - Global Market by Plex - Base/End Year Comparison 
7.3.3 Chart - Global Market by Plex - Base Year 
7.3.4 Chart - Global Market by Plex - End Year 
7.3.5 Chart - Global Market by Plex - Share by Year 
7.3.6 Chart - Global Market by Plex - Segment Growth 
7.4 Global Market by Place - Overview
7.4.1 Table - Global Market by Place
7.4.2 Chart - Global Market by Place - Base/End Year Comparison 
7.4.3 Chart - Global Market by Place - Base Year 
7.4.4 Chart - Global Market by Place - End Year 
7.4.5 Chart - Global Market by Place - Share by Year 
7.4.6 Chart - Global Market by Place - Segments Growth
7.5 Global Market by Product - Overview  
7.5.1 Table - Global Market by Product
7.5.2 Chart - Global Market by Product - Base/End Year Comparison 
7.5.3 Chart - Global Market by Product - Base Year 
7.5.4 Chart - Global Market by Product - End Year 
7.5.5 Chart - Global Market by Product - Share by Year
7.5.6 Chart - Global Market by Product - Segments Growth

8 Global Respiratory Infection Diagnostic Markets - By Technology 
8.1 Microbiology
8.1.1 Table Microbiology - by Country 
8.1.2 Chart - Microbiology Growth 
8.2 PCR 
8.2.1 Table PCR - by Country 
8.2.2 Chart - PCR Growth
8.3 NGS
8.3.1 Table NGS - by Country 
8.3.2 Chart - NGS Growth 
8.4 Immunoassay/Other 
8.4.1 Table Immunoassay - by Country
8.4.2 Chart - Immunoassay/Other Growth 
8.5 C19 Singleplex 
8.5.1 Table C19splex - by Country 
8.5.2 Chart - C19splex Growth 

9 Global Respiratory Infection Diagnostic Markets - by Plex 
9.1 C19 Single Plex
9.1.1 Chart - C19 Single Plex Growth
9.2 Singleplex 
9.2.1 Table Singleplex - by Country 
9.2.2 Chart - Singleplex Growth
9.3 Duplex/Triplex 
9.3.1 Table Duplex/Triplex - by Country 
9.3.2 Chart - Duplex/Triplex Growth 
9.4 Multiplex Technology 
9.4.1 Table Multiplex - by Country 
9.4.2 Chart - Multiplex Growth

10 Global Respiratory Infection Diagnostic Markets - by Place 
10.1 Hospital Lab 
10.1.1 Table Hospital Lab - by Country
10.1.2 Chart - Hospital Lab Growth 
10.2 Outpatient Lab 
10.2.1 Table Outpatient Lab - by Country  
10.2.2 Chart - Outpatient Lab Growth 
10.3 POC 
10.3.1 Table POC - by Country
10.3.2 Chart - POC Growth 
10.4 Other Technology  
10.4.1 Chart - Other Growth 

11 Global Respiratory Infection Diagnostic Markets - by Product 
11.1 Instruments 
11.1.1 Table Instruments - by Country
11.1.2 Chart - Instruments Growth 
11.2 Consumables
11.2.1 Table Consumables - by Country  
11.2.2 Chart - Consumables Growth
11.3 Software & Service 
11.3.1 Table Software & Service - by Country 
11.3.2 Chart - Software & Service Growth  

12 Appendices
12.1 United States Medicare System: January 2021 Clinical Laboratory Fees



List of Figures


 Figure 1 Respiratory Tract Infections 
Figure 2 The LRI Mortality Rate Globally 
Figure 3 Global Pandemic Pathogen Status 
Figure 4 Medicare Clinical Lab Expenditures 2004 to 2020 ($Million)
Figure 5 The BioFire Respiratory Panel 
Figure 6 Pneumonia 
Figure 7 Bacterial Infections of the Respiratory Tract
Figure 8 The Development Cycle of Tuberculosis 
Figure 9 A Flu Epidemic in Europe - Historical Pattern 
Figure 10 The Single Multiplex Shift 
Figure 11 Percentage of World Population Over 65 
Figure 12 Global Market Share Chart 
Figure 13 Global Market by Technology - Base vs. End Year 
Figure 14 Global Market by Technology Base Year 
Figure 15 Global Market by Technology End Year 
Figure 16 Technology Share by Year 
Figure 17 Technology Segments Growth 
Figure 18 Plex - Base vs. End Year Segment Shift
Figure 19 Plex Market Base Year 
Figure 20 Plex Market End Year 
Figure 21 Plex Share by Year  
Figure 22 Plex Segments Growth
Figure 23 Place - Base vs. End Year 
Figure 24 Place Market Base Year 
Figure 25 Place Market End Year 
Figure 26 Place Share by Year 
Figure 27 Place Segments Growth
Figure 28 Product - Base vs. End Year 
Figure 29 Product Market Base Year 
Figure 30 Product Market End Year 
Figure 31 Product Share by Year
Figure 32 Product Segments Growth 
Figure 33 Microbiology Growth 
Figure 34 PCR Diagnostics Growth
Figure 35 NGS Growth 
Figure 36 Immunoassay/Other Growth 
Figure 37 C19splex Growth  
Figure 38 C19 Single Plex Growth
Figure 39 Singleplex Growth 
Figure 40 Duplex/Triplex Growth 
Figure 41 Multiplex Growth  
Figure 42 Hospital Lab Growth 
Figure 43 Outpatient Lab Growth 
Figure 44 POC Growth 
Figure 45 Other Growth
Figure 46 Instruments Growth 
Figure 47 Consumables Growth
Figure 48 Software & Service Growth 

List of Tables


Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2014 to 2020 ($million)
Table 2 Market Players by Type
Table 3 Bacterial Causes of Pneumonia 
Table 4 List of Influenza Pandemics 
Table 5 Viral Infections of the Respiratory Tract 
Table 6 Fungal Infections of the Respiratory Tract 
Table 7 Characteristics of Coronavirus Pandemic Infections 
Table 8 COVID-19 Symptoms 
Table 9 Five Factors Driving Growth 
Table 10 Three Factors Limiting Growth
Table 11 Key Diagnostic Laboratory Technology Trends
Table 12 Long Term Pathoghen Identification Timetable 
Table 13 - Global Market by Region
Table 14 Global Market by Technology 
Table 15 Global Market by Plex 
Table 16 Global Market by Place 
Table 17 Global Market by Product 
Table 18 Microbiology by Country
Table 19 PCR by Country 
Table 20 NGS by Country
Table 21 Immunoassay/Other by Country 
Table 22 C19splex by Country
Table 23 C19 Single Plex by Country 
Table 24 Singleplex by Country 
Table 25 Duplex/Triplex by Country 
Table 26 Multiplex by Country 
Table 27 Hospital Lab by Country 
Table 28 Outpatient Lab by Country
Table 29 POC by Country 
Table 30 Other by Country 
Table 31 Instruments by Country 
Table 32 Consumables by Country
Table 33 Software & Service by Country 
Table 34 2021 Laboratory Fee Schedule